{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-135566","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2021-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.860005+00:00","generated_at":"2026-06-28T11:45:25.444509+00:00","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Semper Paratus closes $345M SPAC IPO; $351.9M placed in trust","bullets":["Closed IPO of 34.5M units at $10.00 each, including full exercise of 4.5M-unit over-allotment.","Gross IPO proceeds of $345M; private placement of 1.3M units to sponsor ($13M) and 150K units to Cantor ($1.5M).","Trust account funded with $351.9M from IPO proceeds and private placements; 15-month deadline for business combination.","Brad Stewart and Parizad Olver Parchi appointed to board; audit and compensation committees formed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-135566","json":"https://secwatch.observer/filing/0001104659-21-135566.json","markdown":"https://secwatch.observer/filing/0001104659-21-135566.md","text":"https://secwatch.observer/filing/0001104659-21-135566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/tm2132195d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T11:45:25.444509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8531e6eddb","claim":"Brad Stewart was appointed as Director at Tevogen Bio Holdings Inc..","evidence_excerpt":"Effective November 3, 2021, Brad Stewart and Parizad Olver Parchi were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8e9fe45593","claim":"Parizad Olver Parchi was appointed as Director at Tevogen Bio Holdings Inc..","evidence_excerpt":"Effective November 3, 2021, Brad Stewart and Parizad Olver Parchi were appointed to the board of directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000110465921135566/0001104659-21-135566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}